Home » BRC News

BRC News

UCLH clinicians and UCL researchers have started an international academic-industrial collaboration – EpiFemCare – to develop new methods for screening, diagnosing and personalising treatment of breast and ovarian cancers.
UCL scientists are on the team which has just determined the first full pig genome sequence. Determining the full pig genome sequence represents a breakthrough because of the human clinical implicationsand paves the way for experimental medicine studies in the BRC. Image courtesy of Michele Studer, Wellcome Images
Current testing strategies for the families of patients with familial hypercholesterolemia (FH) may not be an efficient use of health resources, suggest results published in The Lancet.  Image courtesy of NHS Photo Library
Researchers have carried out the first extensive analysis of genetic variants associated with Hypertrophic cardiomyopathy (HCM), the most common cause of sudden cardiac death. Their work will enable the development of new risk prediction tools to guide medical intervention.
Researchers have calculated that the cost of the rare disease Friedreich's Ataxia is between £11,000 and £19,000 per person per year. Their work has shown that the costs of rare diseases need to be worked out rather than basing estimates on the costs of other conditions.
Staff from across UCLH were honoured at a special awards ceremony last night which included for the first time a ‘Contribution to World Class Research’ category.